Evidence map›Paper›PMID 34054546›Full record

ArticleFrontiers in pharmacology2021

Therapeutic Effects of Naringin in Rheumatoid Arthritis: Network Pharmacology and Experimental Validation.

Yirixiati Aihaiti, Yong Song Cai, Xiadiye Tuerhong, Yan Ni Yang, Yao Ma, Hai Shi Zheng, Ke Xu, Peng Xu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yirixiati AihaitiDepartment of Joint Surgery, Xi'an Jiaotong University Affiliated HongHui Hospital, Xi'an, China.
Yong Song CaiDepartment of Joint Surgery, Xi'an Jiaotong University Affiliated HongHui Hospital, Xi'an, China.
Xiadiye TuerhongDepartment of Thoracic Surgery, Xi'an Jiaotong University Affiliated HongHui Hospital, Xi'an, China.
Yan Ni YangDepartment of Rehabilitation, Xi'an Jiaotong University Affiliated HongHui Hospital, Xi'an, China.
Yao MaDepartment of Joint Surgery, Xi'an Jiaotong University Affiliated HongHui Hospital, Xi'an, China.
Hai Shi ZhengDepartment of Joint Surgery, Xi'an Jiaotong University Affiliated HongHui Hospital, Xi'an, China.
Ke XuDepartment of Joint Surgery, Xi'an Jiaotong University Affiliated HongHui Hospital, Xi'an, China.
Peng XuDepartment of Joint Surgery, Xi'an Jiaotong University Affiliated HongHui Hospital, Xi'an, China.
Xi'an Honghui Hospital · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis is a chronic autoimmune disease characterized by persistent hyperplasia of the synovial membrane and progressive erosion of articular cartilage. Disequilibrium between the proliferation and death of RA fibroblast-like synoviocytes (RA-FLSs) is the critical factor in progression of RA. Naringin has been reported to exert anti-inflammatory and antioxidant effect in acute and chronic animal models of RA. However, the therapeutic effect and underlying mechanisms of naringin in human RA-FLS remain unclear. Based on network pharmacology, the corresponding targets of naringin were identified using SwissTargetPrediction database, STITCH database, and Comparative Toxicogenomics Database. Deferentially expressed genes (DEGs) in RA were obtained from the GEO database. The protein-protein interaction (PPI) networks of intersected targets were constructed using the STRING database and visualized using Cytoscape. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed, and the pathways directly related to pathogenesis of RA were integrated manually. Further,

Indexed as

MAPK/ERK signaling pathwaynaringinnetwork pharmacologyPI3k/Akt signaling pathwayrheumatoid arthritis

Identifiers

PMID34054546
PMCPMC8160516
OpenAlexW3163638628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.